{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:18:09Z","timestamp":1783034289586,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00475-1","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:53:03Z","timestamp":1777629183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival trends in the management of carcinoid heart disease among patients with neuroendocrine neoplasms"],"prefix":"10.1186","volume":"12","author":[{"given":"Sarah","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M","family":"Switchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mandawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-4725","authenticated-orcid":false,"given":"Olatunji B.","family":"Alese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"3","key":"475_CR1","doi-asserted-by":"publisher","first-page":"G177","DOI":"10.1152\/ajpgi.00205.2022","volume":"324","author":"Y Sei","year":"2023","unstructured":"Sei Y, Feng J, Zhao X, Dagur P, McCoy JP, Merchant JL, et al. Tissue- and cell-specific properties of enterochromaffin cells affect the fate of tumorigenesis toward nonendocrine adenocarcinoma of the small intestine. Am J Physiol Gastrointest Liver Physiol. 2023;324(3):G177\u201389.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"475_CR2","unstructured":"Evers BM. Carcinoid Syndrome due to Neuroendocrine Tumors, (2024). https:\/\/www.merckmanuals.com\/home\/hormonal-and-metabolic-disorders\/gastrointestinal-and-pancreatic-neuroendocrine-tumors\/carcinoid-syndrome-due-to-neuroendocrine-tumors."},{"issue":"12","key":"475_CR3","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1530\/EC-19-0413","volume":"8","author":"R Steeds","year":"2019","unstructured":"Steeds R, Sagar V, Shetty S, Oelofse T, Singh H, Ahmad R, et al. Multidisciplinary team management of carcinoid heart disease. Endocr Connect. 2019;8(12):R184\u201399.","journal-title":"Endocr Connect"},{"issue":"41","key":"475_CR4","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"2","key":"475_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.amjsurg.2022.03.054","volume":"224","author":"R Macfie","year":"2022","unstructured":"Macfie R, McCully BH, Ratzlaff AN, Lim J, Song HK, Dewey EN, et al. The prevalence, operations, and outcomes of carcinoid heart disease. Am J Surg. 2022;224(2):665\u20139.","journal-title":"Am J Surg"},{"issue":"10","key":"475_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","volume":"69","author":"J Davar","year":"2017","unstructured":"Davar J, Connolly HM, Caplin ME, Pavel M, Zacks J, Bhattacharyya S, et al. Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement. J Am Coll Cardiol. 2017;69(10):1288\u2013304.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"475_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/00365520903082432","volume":"44","author":"DS Bergestuen","year":"2009","unstructured":"Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E. Small intestinal neuroendocrine tumors: prognostic factors and survival. Scand J Gastroenterol. 2009;44(9):1084\u201391.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"475_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","volume":"87","author":"PA Pellikka","year":"1993","unstructured":"Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87(4):1188\u201396.","journal-title":"Circulation"},{"issue":"3","key":"475_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14740\/jmc3452","volume":"11","author":"A Sanchez-Nadales","year":"2020","unstructured":"Sanchez-Nadales A, Celis-Barreto V, Anampa-Guzman A, Salazar-Leon M, Contreras-Chavez P. Carcinoid Right Heart Disease. J Med Cases. 2020;11(3):73\u20136.","journal-title":"J Med Cases"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"1353612","DOI":"10.3389\/fcvm.2024.1353612","volume":"11","author":"J Namkoong","year":"2024","unstructured":"Namkoong J, Andraweera PH, Pathirana M, Munawar D, Downie M, Edwards S, et al. A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease. Front Cardiovasc Med. 2024;11:1353612.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"475_CR11","doi-asserted-by":"publisher","first-page":"e13146","DOI":"10.1111\/jne.13146","volume":"34","author":"S Grozinsky-Glasberg","year":"2022","unstructured":"Grozinsky-Glasberg S, Davar J, Hofland J, Dobson R, Prasad V, Pascher A, et al. European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease. J Neuroendocrinol. 2022;34(7):e13146.","journal-title":"J Neuroendocrinol"},{"issue":"23","key":"475_CR12","doi-asserted-by":"publisher","first-page":"e020475","DOI":"10.1161\/JAHA.120.020475","volume":"10","author":"E Baron","year":"2021","unstructured":"Baron E, Szymanski C, Hergault H, Lep\u00e8re C, Dubourg O, Hauguel-Moreau M, et al. Progression of Carcinoid Heart Disease in the Modern Management Era. J Am Heart Assoc. 2021;10(23):e020475.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"475_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","volume":"101","author":"S Bhattacharyya","year":"2008","unstructured":"Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol. 2008;101(3):378\u201381.","journal-title":"Am J Cardiol"},{"key":"475_CR14","doi-asserted-by":"crossref","unstructured":"Kostiainen I, Simonen P, Aaltonen K, Lind\u00e9n R, Karppinen N, Gordin D et al. The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors. Cancers (Basel). 2024;16(23).","DOI":"10.3390\/cancers16233896"},{"issue":"8","key":"475_CR15","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.21037\/tcr-23-248","volume":"12","author":"Z Tao","year":"2023","unstructured":"Tao Z, Xue R, Wei Z, Qin L, Bai R, Liu N, et al. The assessment of Ki-67 for prognosis of gastroenteropancreatic neuroendocrine neoplasm patients: a systematic review and meta-analysis. Transl Cancer Res. 2023;12(8):1980\u201391.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"475_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","volume":"92","author":"PA Robiolio","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, et al. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995;92(4):790\u20135.","journal-title":"Circulation"},{"issue":"11","key":"475_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021451","volume":"348","author":"JE M\u00f8ller","year":"2003","unstructured":"M\u00f8ller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors associated with progression of carcinoid heart disease. N Engl J Med. 2003;348(11):1005\u201315.","journal-title":"N Engl J Med"},{"issue":"1","key":"475_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12885-023-10739-z","volume":"23","author":"E Grundmann","year":"2023","unstructured":"Grundmann E, Curioni-Fontecedro A, Christ E, Siebenh\u00fcner AR. Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort. BMC Cancer. 2023;23(1):338.","journal-title":"BMC Cancer"},{"issue":"11","key":"475_CR19","doi-asserted-by":"publisher","first-page":"103959","DOI":"10.1016\/j.esmoop.2024.103959","volume":"9","author":"L Algeri","year":"2024","unstructured":"Algeri L, Falkman L, Spada F, Frassoni S, Bagnardi V, Boselli S, et al. Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers. ESMO Open. 2024;9(11):103959.","journal-title":"ESMO Open"},{"issue":"4","key":"475_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40618-023-02213-1","volume":"47","author":"RM Ruggeri","year":"2024","unstructured":"Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, et al. Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study. J Endocrinol Invest. 2024;47(4):959\u201371.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"475_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000381930","volume":"101","author":"S Grozinsky-Glasberg","year":"2015","unstructured":"Grozinsky-Glasberg S, Grossman AB, Gross DJ. Carcinoid Heart Disease: From Pathophysiology to Treatment - \u2018Something in the Way It Moves\u2019. Neuroendocrinology. 2015;101(4):263\u201373.","journal-title":"Neuroendocrinology"},{"key":"475_CR22","doi-asserted-by":"crossref","unstructured":"Uema D, Alves C, Mesquita M, Nu\u00f1ez JE, Siepmann T, Angel M et al. Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study. J Clin Med. 2019;8(3).","DOI":"10.3390\/jcm8030405"},{"issue":"9","key":"475_CR23","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/bjc.2014.468","volume":"111","author":"R Dobson","year":"2014","unstructured":"Dobson R, Burgess MI, Valle JW, Pritchard DM, Vora J, Wong C, et al. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality. Br J Cancer. 2014;111(9):1703\u20139.","journal-title":"Br J Cancer"},{"key":"475_CR24","doi-asserted-by":"crossref","unstructured":"Kuhnly N, Coviello JS, Kobza CA, Patel DA, Lagoy JS, Cyr M-AL. Carcinoid Heart Disease JADPRO. 2024;15.","DOI":"10.6004\/jadpro.2024.15.6.3"},{"issue":"1","key":"475_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14503\/THIJ-17-6562","volume":"46","author":"P Ram","year":"2019","unstructured":"Ram P, Penalver JL, Lo KBU, Rangaswami J, Pressman GS. Carcinoid Heart Disease: Review of Current Knowledge. Tex Heart Inst J. 2019;46(1):21\u20137.","journal-title":"Tex Heart Inst J"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00475-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:39:59Z","timestamp":1783031999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00475-1","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by the Emory University Institutional Review Board at Emory University. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee\/institutional review board waived the requirement of written informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}